nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2B6—Clopidogrel—coronary artery disease	0.0376	0.0544	CbGbCtD
Nevirapine—CYP3A5—Clopidogrel—coronary artery disease	0.0296	0.0428	CbGbCtD
Nevirapine—CYP2C9—Fenofibrate—coronary artery disease	0.0287	0.0415	CbGbCtD
Nevirapine—CYP3A5—Eplerenone—coronary artery disease	0.0276	0.0398	CbGbCtD
Nevirapine—CYP1A2—Gemfibrozil—coronary artery disease	0.0255	0.0368	CbGbCtD
Nevirapine—CYP2C9—Gemfibrozil—coronary artery disease	0.0229	0.0331	CbGbCtD
Nevirapine—CYP2B6—Simvastatin—coronary artery disease	0.0225	0.0326	CbGbCtD
Nevirapine—CYP1A2—Clopidogrel—coronary artery disease	0.0221	0.0319	CbGbCtD
Nevirapine—CYP2B6—Atorvastatin—coronary artery disease	0.0201	0.029	CbGbCtD
Nevirapine—CYP2C9—Clopidogrel—coronary artery disease	0.0199	0.0287	CbGbCtD
Nevirapine—CYP3A5—Rosuvastatin—coronary artery disease	0.0191	0.0276	CbGbCtD
Nevirapine—CYP3A4—Ticagrelor—coronary artery disease	0.0187	0.027	CbGbCtD
Nevirapine—CYP3A5—Simvastatin—coronary artery disease	0.0178	0.0257	CbGbCtD
Nevirapine—CYP3A5—Lovastatin—coronary artery disease	0.0174	0.0251	CbGbCtD
Nevirapine—CYP3A5—Pravastatin—coronary artery disease	0.0174	0.0251	CbGbCtD
Nevirapine—CYP2C9—Pitavastatin—coronary artery disease	0.0174	0.0251	CbGbCtD
Nevirapine—CYP2C9—Valsartan—coronary artery disease	0.0169	0.0244	CbGbCtD
Nevirapine—CYP3A4—Fenofibrate—coronary artery disease	0.0167	0.0241	CbGbCtD
Nevirapine—CYP3A5—Atorvastatin—coronary artery disease	0.0158	0.0229	CbGbCtD
Nevirapine—CYP3A5—Losartan—coronary artery disease	0.0145	0.0209	CbGbCtD
Nevirapine—CYP2D6—Niacin—coronary artery disease	0.0138	0.0199	CbGbCtD
Nevirapine—CYP3A4—Gemfibrozil—coronary artery disease	0.0133	0.0193	CbGbCtD
Nevirapine—CYP2C9—Rosuvastatin—coronary artery disease	0.0128	0.0185	CbGbCtD
Nevirapine—CYP2D6—Timolol—coronary artery disease	0.0128	0.0185	CbGbCtD
Nevirapine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0125	0.018	CbGbCtD
Nevirapine—CYP2C9—Simvastatin—coronary artery disease	0.0119	0.0172	CbGbCtD
Nevirapine—CYP2C9—Lovastatin—coronary artery disease	0.0117	0.0168	CbGbCtD
Nevirapine—CYP2C9—Pravastatin—coronary artery disease	0.0117	0.0168	CbGbCtD
Nevirapine—CYP3A4—Clopidogrel—coronary artery disease	0.0116	0.0167	CbGbCtD
Nevirapine—CYP2D6—Captopril—coronary artery disease	0.0113	0.0163	CbGbCtD
Nevirapine—CYP2D6—Simvastatin—coronary artery disease	0.0109	0.0157	CbGbCtD
Nevirapine—CYP1A2—Losartan—coronary artery disease	0.0108	0.0156	CbGbCtD
Nevirapine—CYP3A4—Eplerenone—coronary artery disease	0.0107	0.0155	CbGbCtD
Nevirapine—CYP2D6—Pravastatin—coronary artery disease	0.0107	0.0154	CbGbCtD
Nevirapine—CYP2D6—Lovastatin—coronary artery disease	0.0107	0.0154	CbGbCtD
Nevirapine—CYP2C9—Atorvastatin—coronary artery disease	0.0106	0.0153	CbGbCtD
Nevirapine—CYP2C9—Losartan—coronary artery disease	0.00971	0.014	CbGbCtD
Nevirapine—CYP2D6—Atorvastatin—coronary artery disease	0.00971	0.014	CbGbCtD
Nevirapine—CYP3A4—Enalapril—coronary artery disease	0.00958	0.0138	CbGbCtD
Nevirapine—CYP3A4—Rosuvastatin—coronary artery disease	0.00745	0.0108	CbGbCtD
Nevirapine—CYP3A4—Ezetimibe—coronary artery disease	0.00745	0.0108	CbGbCtD
Nevirapine—CYP3A4—Simvastatin—coronary artery disease	0.00693	0.01	CbGbCtD
Nevirapine—CYP3A4—Pravastatin—coronary artery disease	0.00678	0.0098	CbGbCtD
Nevirapine—CYP3A4—Lovastatin—coronary artery disease	0.00678	0.0098	CbGbCtD
Nevirapine—CYP3A4—Atorvastatin—coronary artery disease	0.00617	0.00892	CbGbCtD
Nevirapine—CYP3A4—Losartan—coronary artery disease	0.00565	0.00816	CbGbCtD
Nevirapine—Feeling abnormal—Captopril—coronary artery disease	0.000102	0.000415	CcSEcCtD
Nevirapine—Rash—Fenofibrate—coronary artery disease	0.000102	0.000414	CcSEcCtD
Nevirapine—Dermatitis—Fenofibrate—coronary artery disease	0.000102	0.000414	CcSEcCtD
Nevirapine—Decreased appetite—Furosemide—coronary artery disease	0.000101	0.000413	CcSEcCtD
Nevirapine—Headache—Fenofibrate—coronary artery disease	0.000101	0.000412	CcSEcCtD
Nevirapine—Paraesthesia—Losartan—coronary artery disease	0.000101	0.000412	CcSEcCtD
Nevirapine—Gastrointestinal pain—Captopril—coronary artery disease	0.000101	0.000412	CcSEcCtD
Nevirapine—Urticaria—Telmisartan—coronary artery disease	0.000101	0.000411	CcSEcCtD
Nevirapine—Vomiting—Clopidogrel—coronary artery disease	0.000101	0.000411	CcSEcCtD
Nevirapine—Diarrhoea—Simvastatin—coronary artery disease	0.000101	0.000411	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000101	0.00041	CcSEcCtD
Nevirapine—Arthralgia—Ramipril—coronary artery disease	0.000101	0.00041	CcSEcCtD
Nevirapine—Myalgia—Ramipril—coronary artery disease	0.000101	0.00041	CcSEcCtD
Nevirapine—Fatigue—Furosemide—coronary artery disease	0.000101	0.00041	CcSEcCtD
Nevirapine—Body temperature increased—Telmisartan—coronary artery disease	0.000101	0.000409	CcSEcCtD
Nevirapine—Abdominal pain—Telmisartan—coronary artery disease	0.000101	0.000409	CcSEcCtD
Nevirapine—Vomiting—Lovastatin—coronary artery disease	0.0001	0.000408	CcSEcCtD
Nevirapine—Somnolence—Losartan—coronary artery disease	0.0001	0.000407	CcSEcCtD
Nevirapine—Rash—Clopidogrel—coronary artery disease	0.0001	0.000407	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.0001	0.000407	CcSEcCtD
Nevirapine—Dermatitis—Clopidogrel—coronary artery disease	0.0001	0.000407	CcSEcCtD
Nevirapine—Asthenia—Valsartan—coronary artery disease	9.99e-05	0.000407	CcSEcCtD
Nevirapine—Pain—Furosemide—coronary artery disease	9.98e-05	0.000406	CcSEcCtD
Nevirapine—Hypersensitivity—Niacin—coronary artery disease	9.97e-05	0.000406	CcSEcCtD
Nevirapine—Ill-defined disorder—Lisinopril—coronary artery disease	9.96e-05	0.000405	CcSEcCtD
Nevirapine—Discomfort—Ramipril—coronary artery disease	9.95e-05	0.000405	CcSEcCtD
Nevirapine—Asthenia—Olmesartan—coronary artery disease	9.94e-05	0.000405	CcSEcCtD
Nevirapine—Headache—Clopidogrel—coronary artery disease	9.94e-05	0.000405	CcSEcCtD
Nevirapine—Rash—Lovastatin—coronary artery disease	9.94e-05	0.000404	CcSEcCtD
Nevirapine—Dermatitis—Lovastatin—coronary artery disease	9.93e-05	0.000404	CcSEcCtD
Nevirapine—Anaemia—Lisinopril—coronary artery disease	9.92e-05	0.000404	CcSEcCtD
Nevirapine—Feeling abnormal—Perindopril—coronary artery disease	9.89e-05	0.000403	CcSEcCtD
Nevirapine—Headache—Lovastatin—coronary artery disease	9.87e-05	0.000402	CcSEcCtD
Nevirapine—Pruritus—Valsartan—coronary artery disease	9.85e-05	0.000401	CcSEcCtD
Nevirapine—Myalgia—Timolol—coronary artery disease	9.85e-05	0.000401	CcSEcCtD
Nevirapine—Arthralgia—Timolol—coronary artery disease	9.85e-05	0.000401	CcSEcCtD
Nevirapine—Vomiting—Ezetimibe—coronary artery disease	9.83e-05	0.0004	CcSEcCtD
Nevirapine—Hypersensitivity—Pravastatin—coronary artery disease	9.82e-05	0.0004	CcSEcCtD
Nevirapine—Gastrointestinal pain—Perindopril—coronary artery disease	9.82e-05	0.0004	CcSEcCtD
Nevirapine—Angioedema—Lisinopril—coronary artery disease	9.8e-05	0.000399	CcSEcCtD
Nevirapine—Pruritus—Olmesartan—coronary artery disease	9.8e-05	0.000399	CcSEcCtD
Nevirapine—Decreased appetite—Losartan—coronary artery disease	9.79e-05	0.000398	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.78e-05	0.000398	CcSEcCtD
Nevirapine—Body temperature increased—Captopril—coronary artery disease	9.78e-05	0.000398	CcSEcCtD
Nevirapine—Abdominal pain—Captopril—coronary artery disease	9.78e-05	0.000398	CcSEcCtD
Nevirapine—Rash—Ezetimibe—coronary artery disease	9.75e-05	0.000397	CcSEcCtD
Nevirapine—Dermatitis—Ezetimibe—coronary artery disease	9.74e-05	0.000396	CcSEcCtD
Nevirapine—Discomfort—Timolol—coronary artery disease	9.73e-05	0.000396	CcSEcCtD
Nevirapine—Asthenia—Niacin—coronary artery disease	9.71e-05	0.000395	CcSEcCtD
Nevirapine—Fatigue—Losartan—coronary artery disease	9.71e-05	0.000395	CcSEcCtD
Nevirapine—Headache—Ezetimibe—coronary artery disease	9.69e-05	0.000394	CcSEcCtD
Nevirapine—Malaise—Lisinopril—coronary artery disease	9.68e-05	0.000394	CcSEcCtD
Nevirapine—Oedema—Ramipril—coronary artery disease	9.66e-05	0.000393	CcSEcCtD
Nevirapine—Anaphylactic shock—Ramipril—coronary artery disease	9.66e-05	0.000393	CcSEcCtD
Nevirapine—Pain—Losartan—coronary artery disease	9.63e-05	0.000392	CcSEcCtD
Nevirapine—Vomiting—Eplerenone—coronary artery disease	9.62e-05	0.000392	CcSEcCtD
Nevirapine—Feeling abnormal—Furosemide—coronary artery disease	9.62e-05	0.000391	CcSEcCtD
Nevirapine—Nausea—Fenofibrate—coronary artery disease	9.59e-05	0.00039	CcSEcCtD
Nevirapine—Pruritus—Niacin—coronary artery disease	9.58e-05	0.00039	CcSEcCtD
Nevirapine—Asthenia—Pravastatin—coronary artery disease	9.56e-05	0.000389	CcSEcCtD
Nevirapine—Gastrointestinal pain—Furosemide—coronary artery disease	9.54e-05	0.000388	CcSEcCtD
Nevirapine—Rash—Eplerenone—coronary artery disease	9.54e-05	0.000388	CcSEcCtD
Nevirapine—Urticaria—Perindopril—coronary artery disease	9.54e-05	0.000388	CcSEcCtD
Nevirapine—Hypersensitivity—Trandolapril—coronary artery disease	9.54e-05	0.000388	CcSEcCtD
Nevirapine—Dermatitis—Eplerenone—coronary artery disease	9.53e-05	0.000388	CcSEcCtD
Nevirapine—Diarrhoea—Valsartan—coronary artery disease	9.53e-05	0.000388	CcSEcCtD
Nevirapine—Hypersensitivity—Enalapril—coronary artery disease	9.5e-05	0.000387	CcSEcCtD
Nevirapine—Abdominal pain—Perindopril—coronary artery disease	9.49e-05	0.000386	CcSEcCtD
Nevirapine—Body temperature increased—Perindopril—coronary artery disease	9.49e-05	0.000386	CcSEcCtD
Nevirapine—Diarrhoea—Olmesartan—coronary artery disease	9.48e-05	0.000386	CcSEcCtD
Nevirapine—Headache—Eplerenone—coronary artery disease	9.48e-05	0.000386	CcSEcCtD
Nevirapine—Nervous system disorder—Ramipril—coronary artery disease	9.47e-05	0.000385	CcSEcCtD
Nevirapine—Thrombocytopenia—Ramipril—coronary artery disease	9.45e-05	0.000385	CcSEcCtD
Nevirapine—Oedema—Timolol—coronary artery disease	9.44e-05	0.000384	CcSEcCtD
Nevirapine—Anaphylactic shock—Timolol—coronary artery disease	9.44e-05	0.000384	CcSEcCtD
Nevirapine—Pruritus—Pravastatin—coronary artery disease	9.43e-05	0.000384	CcSEcCtD
Nevirapine—Nausea—Clopidogrel—coronary artery disease	9.43e-05	0.000384	CcSEcCtD
Nevirapine—Skin disorder—Ramipril—coronary artery disease	9.38e-05	0.000382	CcSEcCtD
Nevirapine—Vomiting—Simvastatin—coronary artery disease	9.37e-05	0.000382	CcSEcCtD
Nevirapine—Hypersensitivity—Telmisartan—coronary artery disease	9.37e-05	0.000381	CcSEcCtD
Nevirapine—Nausea—Lovastatin—coronary artery disease	9.36e-05	0.000381	CcSEcCtD
Nevirapine—Rash—Simvastatin—coronary artery disease	9.3e-05	0.000378	CcSEcCtD
Nevirapine—Dermatitis—Simvastatin—coronary artery disease	9.29e-05	0.000378	CcSEcCtD
Nevirapine—Asthenia—Trandolapril—coronary artery disease	9.29e-05	0.000378	CcSEcCtD
Nevirapine—Feeling abnormal—Losartan—coronary artery disease	9.28e-05	0.000378	CcSEcCtD
Nevirapine—Urticaria—Furosemide—coronary artery disease	9.27e-05	0.000377	CcSEcCtD
Nevirapine—Diarrhoea—Niacin—coronary artery disease	9.26e-05	0.000377	CcSEcCtD
Nevirapine—Nervous system disorder—Timolol—coronary artery disease	9.26e-05	0.000377	CcSEcCtD
Nevirapine—Asthenia—Enalapril—coronary artery disease	9.25e-05	0.000376	CcSEcCtD
Nevirapine—Headache—Simvastatin—coronary artery disease	9.24e-05	0.000376	CcSEcCtD
Nevirapine—Abdominal pain—Furosemide—coronary artery disease	9.23e-05	0.000375	CcSEcCtD
Nevirapine—Body temperature increased—Furosemide—coronary artery disease	9.23e-05	0.000375	CcSEcCtD
Nevirapine—Gastrointestinal pain—Losartan—coronary artery disease	9.21e-05	0.000375	CcSEcCtD
Nevirapine—Anorexia—Ramipril—coronary artery disease	9.2e-05	0.000375	CcSEcCtD
Nevirapine—Nausea—Ezetimibe—coronary artery disease	9.18e-05	0.000374	CcSEcCtD
Nevirapine—Skin disorder—Timolol—coronary artery disease	9.17e-05	0.000373	CcSEcCtD
Nevirapine—Pruritus—Trandolapril—coronary artery disease	9.16e-05	0.000373	CcSEcCtD
Nevirapine—Arthralgia—Lisinopril—coronary artery disease	9.13e-05	0.000372	CcSEcCtD
Nevirapine—Myalgia—Lisinopril—coronary artery disease	9.13e-05	0.000372	CcSEcCtD
Nevirapine—Asthenia—Telmisartan—coronary artery disease	9.12e-05	0.000371	CcSEcCtD
Nevirapine—Pruritus—Enalapril—coronary artery disease	9.12e-05	0.000371	CcSEcCtD
Nevirapine—Diarrhoea—Pravastatin—coronary artery disease	9.12e-05	0.000371	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	9.07e-05	0.000369	CcSEcCtD
Nevirapine—Discomfort—Lisinopril—coronary artery disease	9.03e-05	0.000367	CcSEcCtD
Nevirapine—Anorexia—Timolol—coronary artery disease	9e-05	0.000366	CcSEcCtD
Nevirapine—Pruritus—Telmisartan—coronary artery disease	9e-05	0.000366	CcSEcCtD
Nevirapine—Nausea—Eplerenone—coronary artery disease	8.99e-05	0.000366	CcSEcCtD
Nevirapine—Urticaria—Losartan—coronary artery disease	8.95e-05	0.000364	CcSEcCtD
Nevirapine—Abdominal pain—Losartan—coronary artery disease	8.9e-05	0.000362	CcSEcCtD
Nevirapine—Body temperature increased—Losartan—coronary artery disease	8.9e-05	0.000362	CcSEcCtD
Nevirapine—Asthenia—Captopril—coronary artery disease	8.87e-05	0.000361	CcSEcCtD
Nevirapine—Diarrhoea—Trandolapril—coronary artery disease	8.86e-05	0.00036	CcSEcCtD
Nevirapine—Vomiting—Valsartan—coronary artery disease	8.85e-05	0.00036	CcSEcCtD
Nevirapine—Diarrhoea—Enalapril—coronary artery disease	8.82e-05	0.000359	CcSEcCtD
Nevirapine—Vomiting—Olmesartan—coronary artery disease	8.81e-05	0.000359	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.8e-05	0.000358	CcSEcCtD
Nevirapine—Rash—Valsartan—coronary artery disease	8.78e-05	0.000357	CcSEcCtD
Nevirapine—Dermatitis—Valsartan—coronary artery disease	8.77e-05	0.000357	CcSEcCtD
Nevirapine—Nausea—Simvastatin—coronary artery disease	8.76e-05	0.000356	CcSEcCtD
Nevirapine—Anaphylactic shock—Lisinopril—coronary artery disease	8.76e-05	0.000356	CcSEcCtD
Nevirapine—Oedema—Lisinopril—coronary artery disease	8.76e-05	0.000356	CcSEcCtD
Nevirapine—Pruritus—Captopril—coronary artery disease	8.75e-05	0.000356	CcSEcCtD
Nevirapine—Rash—Olmesartan—coronary artery disease	8.74e-05	0.000356	CcSEcCtD
Nevirapine—Dermatitis—Olmesartan—coronary artery disease	8.73e-05	0.000355	CcSEcCtD
Nevirapine—Headache—Valsartan—coronary artery disease	8.72e-05	0.000355	CcSEcCtD
Nevirapine—Diarrhoea—Telmisartan—coronary artery disease	8.7e-05	0.000354	CcSEcCtD
Nevirapine—Headache—Olmesartan—coronary artery disease	8.68e-05	0.000353	CcSEcCtD
Nevirapine—Paraesthesia—Ramipril—coronary artery disease	8.67e-05	0.000353	CcSEcCtD
Nevirapine—Asthenia—Perindopril—coronary artery disease	8.61e-05	0.000351	CcSEcCtD
Nevirapine—Vomiting—Niacin—coronary artery disease	8.61e-05	0.00035	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Timolol—coronary artery disease	8.6e-05	0.00035	CcSEcCtD
Nevirapine—Hypersensitivity—Furosemide—coronary artery disease	8.6e-05	0.00035	CcSEcCtD
Nevirapine—Somnolence—Ramipril—coronary artery disease	8.58e-05	0.000349	CcSEcCtD
Nevirapine—Thrombocytopenia—Lisinopril—coronary artery disease	8.57e-05	0.000349	CcSEcCtD
Nevirapine—Rash—Niacin—coronary artery disease	8.54e-05	0.000347	CcSEcCtD
Nevirapine—Dermatitis—Niacin—coronary artery disease	8.53e-05	0.000347	CcSEcCtD
Nevirapine—Skin disorder—Lisinopril—coronary artery disease	8.51e-05	0.000346	CcSEcCtD
Nevirapine—Pruritus—Perindopril—coronary artery disease	8.49e-05	0.000346	CcSEcCtD
Nevirapine—Headache—Niacin—coronary artery disease	8.48e-05	0.000345	CcSEcCtD
Nevirapine—Paraesthesia—Timolol—coronary artery disease	8.48e-05	0.000345	CcSEcCtD
Nevirapine—Vomiting—Pravastatin—coronary artery disease	8.48e-05	0.000345	CcSEcCtD
Nevirapine—Diarrhoea—Captopril—coronary artery disease	8.46e-05	0.000344	CcSEcCtD
Nevirapine—Rash—Pravastatin—coronary artery disease	8.4e-05	0.000342	CcSEcCtD
Nevirapine—Dermatitis—Pravastatin—coronary artery disease	8.4e-05	0.000342	CcSEcCtD
Nevirapine—Decreased appetite—Ramipril—coronary artery disease	8.39e-05	0.000342	CcSEcCtD
Nevirapine—Somnolence—Timolol—coronary artery disease	8.39e-05	0.000342	CcSEcCtD
Nevirapine—Asthenia—Furosemide—coronary artery disease	8.37e-05	0.000341	CcSEcCtD
Nevirapine—Headache—Pravastatin—coronary artery disease	8.35e-05	0.00034	CcSEcCtD
Nevirapine—Anorexia—Lisinopril—coronary artery disease	8.35e-05	0.00034	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Ramipril—coronary artery disease	8.34e-05	0.000339	CcSEcCtD
Nevirapine—Fatigue—Ramipril—coronary artery disease	8.32e-05	0.000339	CcSEcCtD
Nevirapine—Hypersensitivity—Losartan—coronary artery disease	8.3e-05	0.000338	CcSEcCtD
Nevirapine—Nausea—Valsartan—coronary artery disease	8.27e-05	0.000337	CcSEcCtD
Nevirapine—Pruritus—Furosemide—coronary artery disease	8.26e-05	0.000336	CcSEcCtD
Nevirapine—Nausea—Olmesartan—coronary artery disease	8.23e-05	0.000335	CcSEcCtD
Nevirapine—Vomiting—Trandolapril—coronary artery disease	8.23e-05	0.000335	CcSEcCtD
Nevirapine—Diarrhoea—Perindopril—coronary artery disease	8.21e-05	0.000334	CcSEcCtD
Nevirapine—Decreased appetite—Timolol—coronary artery disease	8.21e-05	0.000334	CcSEcCtD
Nevirapine—Vomiting—Enalapril—coronary artery disease	8.2e-05	0.000334	CcSEcCtD
Nevirapine—Rash—Trandolapril—coronary artery disease	8.16e-05	0.000332	CcSEcCtD
Nevirapine—Dermatitis—Trandolapril—coronary artery disease	8.15e-05	0.000332	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Timolol—coronary artery disease	8.15e-05	0.000332	CcSEcCtD
Nevirapine—Fatigue—Timolol—coronary artery disease	8.14e-05	0.000331	CcSEcCtD
Nevirapine—Rash—Enalapril—coronary artery disease	8.13e-05	0.000331	CcSEcCtD
Nevirapine—Dermatitis—Enalapril—coronary artery disease	8.12e-05	0.000331	CcSEcCtD
Nevirapine—Headache—Trandolapril—coronary artery disease	8.11e-05	0.00033	CcSEcCtD
Nevirapine—Vomiting—Telmisartan—coronary artery disease	8.09e-05	0.000329	CcSEcCtD
Nevirapine—Asthenia—Losartan—coronary artery disease	8.08e-05	0.000329	CcSEcCtD
Nevirapine—Headache—Enalapril—coronary artery disease	8.08e-05	0.000329	CcSEcCtD
Nevirapine—Pain—Timolol—coronary artery disease	8.07e-05	0.000329	CcSEcCtD
Nevirapine—Nausea—Niacin—coronary artery disease	8.04e-05	0.000327	CcSEcCtD
Nevirapine—Rash—Telmisartan—coronary artery disease	8.02e-05	0.000326	CcSEcCtD
Nevirapine—Dermatitis—Telmisartan—coronary artery disease	8.01e-05	0.000326	CcSEcCtD
Nevirapine—Diarrhoea—Furosemide—coronary artery disease	7.99e-05	0.000325	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.98e-05	0.000325	CcSEcCtD
Nevirapine—Pruritus—Losartan—coronary artery disease	7.97e-05	0.000324	CcSEcCtD
Nevirapine—Headache—Telmisartan—coronary artery disease	7.97e-05	0.000324	CcSEcCtD
Nevirapine—Feeling abnormal—Ramipril—coronary artery disease	7.96e-05	0.000324	CcSEcCtD
Nevirapine—Nausea—Pravastatin—coronary artery disease	7.92e-05	0.000322	CcSEcCtD
Nevirapine—Gastrointestinal pain—Ramipril—coronary artery disease	7.9e-05	0.000321	CcSEcCtD
Nevirapine—Paraesthesia—Lisinopril—coronary artery disease	7.86e-05	0.00032	CcSEcCtD
Nevirapine—Vomiting—Captopril—coronary artery disease	7.86e-05	0.00032	CcSEcCtD
Nevirapine—Rash—Captopril—coronary artery disease	7.8e-05	0.000317	CcSEcCtD
Nevirapine—Dermatitis—Captopril—coronary artery disease	7.79e-05	0.000317	CcSEcCtD
Nevirapine—Somnolence—Lisinopril—coronary artery disease	7.78e-05	0.000317	CcSEcCtD
Nevirapine—Feeling abnormal—Timolol—coronary artery disease	7.78e-05	0.000317	CcSEcCtD
Nevirapine—Headache—Captopril—coronary artery disease	7.75e-05	0.000315	CcSEcCtD
Nevirapine—Gastrointestinal pain—Timolol—coronary artery disease	7.72e-05	0.000314	CcSEcCtD
Nevirapine—Diarrhoea—Losartan—coronary artery disease	7.7e-05	0.000314	CcSEcCtD
Nevirapine—Nausea—Trandolapril—coronary artery disease	7.69e-05	0.000313	CcSEcCtD
Nevirapine—Urticaria—Ramipril—coronary artery disease	7.67e-05	0.000312	CcSEcCtD
Nevirapine—Nausea—Enalapril—coronary artery disease	7.66e-05	0.000312	CcSEcCtD
Nevirapine—Vomiting—Perindopril—coronary artery disease	7.63e-05	0.000311	CcSEcCtD
Nevirapine—Body temperature increased—Ramipril—coronary artery disease	7.63e-05	0.000311	CcSEcCtD
Nevirapine—Abdominal pain—Ramipril—coronary artery disease	7.63e-05	0.000311	CcSEcCtD
Nevirapine—Decreased appetite—Lisinopril—coronary artery disease	7.61e-05	0.00031	CcSEcCtD
Nevirapine—Rash—Perindopril—coronary artery disease	7.57e-05	0.000308	CcSEcCtD
Nevirapine—Dermatitis—Perindopril—coronary artery disease	7.56e-05	0.000308	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.56e-05	0.000308	CcSEcCtD
Nevirapine—Nausea—Telmisartan—coronary artery disease	7.55e-05	0.000307	CcSEcCtD
Nevirapine—Fatigue—Lisinopril—coronary artery disease	7.55e-05	0.000307	CcSEcCtD
Nevirapine—Headache—Perindopril—coronary artery disease	7.52e-05	0.000306	CcSEcCtD
Nevirapine—Urticaria—Timolol—coronary artery disease	7.5e-05	0.000305	CcSEcCtD
Nevirapine—Pain—Lisinopril—coronary artery disease	7.49e-05	0.000305	CcSEcCtD
Nevirapine—Body temperature increased—Timolol—coronary artery disease	7.46e-05	0.000304	CcSEcCtD
Nevirapine—Abdominal pain—Timolol—coronary artery disease	7.46e-05	0.000304	CcSEcCtD
Nevirapine—Vomiting—Furosemide—coronary artery disease	7.42e-05	0.000302	CcSEcCtD
Nevirapine—Rash—Furosemide—coronary artery disease	7.36e-05	0.000299	CcSEcCtD
Nevirapine—Dermatitis—Furosemide—coronary artery disease	7.35e-05	0.000299	CcSEcCtD
Nevirapine—Nausea—Captopril—coronary artery disease	7.34e-05	0.000299	CcSEcCtD
Nevirapine—Headache—Furosemide—coronary artery disease	7.31e-05	0.000298	CcSEcCtD
Nevirapine—Feeling abnormal—Lisinopril—coronary artery disease	7.22e-05	0.000294	CcSEcCtD
Nevirapine—Gastrointestinal pain—Lisinopril—coronary artery disease	7.16e-05	0.000291	CcSEcCtD
Nevirapine—Vomiting—Losartan—coronary artery disease	7.16e-05	0.000291	CcSEcCtD
Nevirapine—Nausea—Perindopril—coronary artery disease	7.13e-05	0.00029	CcSEcCtD
Nevirapine—Hypersensitivity—Ramipril—coronary artery disease	7.11e-05	0.00029	CcSEcCtD
Nevirapine—Rash—Losartan—coronary artery disease	7.1e-05	0.000289	CcSEcCtD
Nevirapine—Dermatitis—Losartan—coronary artery disease	7.09e-05	0.000289	CcSEcCtD
Nevirapine—Headache—Losartan—coronary artery disease	7.05e-05	0.000287	CcSEcCtD
Nevirapine—Urticaria—Lisinopril—coronary artery disease	6.96e-05	0.000283	CcSEcCtD
Nevirapine—Hypersensitivity—Timolol—coronary artery disease	6.95e-05	0.000283	CcSEcCtD
Nevirapine—Nausea—Furosemide—coronary artery disease	6.93e-05	0.000282	CcSEcCtD
Nevirapine—Asthenia—Ramipril—coronary artery disease	6.93e-05	0.000282	CcSEcCtD
Nevirapine—Body temperature increased—Lisinopril—coronary artery disease	6.92e-05	0.000282	CcSEcCtD
Nevirapine—Abdominal pain—Lisinopril—coronary artery disease	6.92e-05	0.000282	CcSEcCtD
Nevirapine—Pruritus—Ramipril—coronary artery disease	6.83e-05	0.000278	CcSEcCtD
Nevirapine—Asthenia—Timolol—coronary artery disease	6.77e-05	0.000276	CcSEcCtD
Nevirapine—Nausea—Losartan—coronary artery disease	6.69e-05	0.000272	CcSEcCtD
Nevirapine—Pruritus—Timolol—coronary artery disease	6.68e-05	0.000272	CcSEcCtD
Nevirapine—Diarrhoea—Ramipril—coronary artery disease	6.61e-05	0.000269	CcSEcCtD
Nevirapine—Diarrhoea—Timolol—coronary artery disease	6.46e-05	0.000263	CcSEcCtD
Nevirapine—Hypersensitivity—Lisinopril—coronary artery disease	6.45e-05	0.000263	CcSEcCtD
Nevirapine—Asthenia—Lisinopril—coronary artery disease	6.28e-05	0.000256	CcSEcCtD
Nevirapine—Pruritus—Lisinopril—coronary artery disease	6.2e-05	0.000252	CcSEcCtD
Nevirapine—Vomiting—Ramipril—coronary artery disease	6.14e-05	0.00025	CcSEcCtD
Nevirapine—Rash—Ramipril—coronary artery disease	6.09e-05	0.000248	CcSEcCtD
Nevirapine—Dermatitis—Ramipril—coronary artery disease	6.08e-05	0.000248	CcSEcCtD
Nevirapine—Headache—Ramipril—coronary artery disease	6.05e-05	0.000246	CcSEcCtD
Nevirapine—Vomiting—Timolol—coronary artery disease	6e-05	0.000244	CcSEcCtD
Nevirapine—Diarrhoea—Lisinopril—coronary artery disease	5.99e-05	0.000244	CcSEcCtD
Nevirapine—Rash—Timolol—coronary artery disease	5.95e-05	0.000242	CcSEcCtD
Nevirapine—Dermatitis—Timolol—coronary artery disease	5.95e-05	0.000242	CcSEcCtD
Nevirapine—Headache—Timolol—coronary artery disease	5.91e-05	0.000241	CcSEcCtD
Nevirapine—Nausea—Ramipril—coronary artery disease	5.74e-05	0.000233	CcSEcCtD
Nevirapine—Nausea—Timolol—coronary artery disease	5.61e-05	0.000228	CcSEcCtD
Nevirapine—Vomiting—Lisinopril—coronary artery disease	5.57e-05	0.000227	CcSEcCtD
Nevirapine—Rash—Lisinopril—coronary artery disease	5.52e-05	0.000225	CcSEcCtD
Nevirapine—Dermatitis—Lisinopril—coronary artery disease	5.52e-05	0.000224	CcSEcCtD
Nevirapine—Headache—Lisinopril—coronary artery disease	5.49e-05	0.000223	CcSEcCtD
Nevirapine—Nausea—Lisinopril—coronary artery disease	5.2e-05	0.000212	CcSEcCtD
Nevirapine—CYP2C9—Metabolism—HBA1—coronary artery disease	7.26e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LDLR—coronary artery disease	7.23e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOC3—coronary artery disease	7.21e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	7.21e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—MTHFR—coronary artery disease	7.17e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LDLR—coronary artery disease	7.17e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	7.16e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTT1—coronary artery disease	7.15e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	7.15e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTP1—coronary artery disease	7.13e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.12e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PDHA1—coronary artery disease	7.09e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GCLM—coronary artery disease	7.09e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTT1—coronary artery disease	7.08e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC9A1—coronary artery disease	7.08e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CETP—coronary artery disease	7.06e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GCLC—coronary artery disease	7.06e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARGC1A—coronary artery disease	7.06e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7.04e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HMOX1—coronary artery disease	7.03e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GCLC—coronary artery disease	7e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CETP—coronary artery disease	7e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SDC1—coronary artery disease	6.99e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTP1—coronary artery disease	6.97e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CAT—coronary artery disease	6.94e-06	0.000111	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SDC1—coronary artery disease	6.92e-06	0.000111	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	6.9e-06	0.000111	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HMOX1—coronary artery disease	6.87e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	6.86e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	6.86e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AGT—coronary artery disease	6.82e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—VCAN—coronary artery disease	6.79e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CAT—coronary artery disease	6.78e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	6.76e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALDOA—coronary artery disease	6.74e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOB—coronary artery disease	6.73e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—APOE—coronary artery disease	6.68e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HADH—coronary artery disease	6.66e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ARNTL—coronary artery disease	6.66e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—APOA1—coronary artery disease	6.6e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PSMB5—coronary artery disease	6.6e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PSMA6—coronary artery disease	6.6e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOB—coronary artery disease	6.58e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTM1—coronary artery disease	6.55e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—DCN—coronary artery disease	6.54e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PSMA6—coronary artery disease	6.54e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PSMB5—coronary artery disease	6.54e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	6.53e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CTGF—coronary artery disease	6.45e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—LPL—coronary artery disease	6.43e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTM1—coronary artery disease	6.4e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CTGF—coronary artery disease	6.39e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GOT2—coronary artery disease	6.39e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMGCR—coronary artery disease	6.39e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALDH2—coronary artery disease	6.37e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMGCR—coronary artery disease	6.33e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GOT2—coronary artery disease	6.33e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX2—coronary artery disease	6.32e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	6.32e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA2—coronary artery disease	6.32e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—LPL—coronary artery disease	6.28e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GPX1—coronary artery disease	6.27e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCG5—coronary artery disease	6.24e-06	0.0001	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX4—coronary artery disease	6.24e-06	0.0001	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	6.24e-06	0.0001	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HK1—coronary artery disease	6.24e-06	0.0001	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.21e-06	9.95e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HBA1—coronary artery disease	6.2e-06	9.95e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	6.2e-06	9.95e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LIPC—coronary artery disease	6.2e-06	9.95e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2C19—coronary artery disease	6.2e-06	9.95e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HADHA—coronary artery disease	6.17e-06	9.89e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOC3—coronary artery disease	6.16e-06	9.89e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GPX1—coronary artery disease	6.13e-06	9.83e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LDLR—coronary artery disease	6.13e-06	9.83e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.12e-06	9.82e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CD36—coronary artery disease	6.11e-06	9.8e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA1—coronary artery disease	6.09e-06	9.78e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTT1—coronary artery disease	6.05e-06	9.71e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC9A1—coronary artery disease	6.05e-06	9.71e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPP2CA—coronary artery disease	6.03e-06	9.68e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LPA—coronary artery disease	6.03e-06	9.67e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GCLC—coronary artery disease	5.98e-06	9.6e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CETP—coronary artery disease	5.98e-06	9.6e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CD36—coronary artery disease	5.97e-06	9.58e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SDC1—coronary artery disease	5.92e-06	9.49e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPP2CA—coronary artery disease	5.9e-06	9.46e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PLCB1—coronary artery disease	5.87e-06	9.42e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.84e-06	9.36e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PLCB1—coronary artery disease	5.82e-06	9.34e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARG—coronary artery disease	5.82e-06	9.33e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MTHFR—coronary artery disease	5.79e-06	9.29e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA5—coronary artery disease	5.78e-06	9.27e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—POMC—coronary artery disease	5.74e-06	9.2e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.71e-06	9.16e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCA1—coronary artery disease	5.69e-06	9.13e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—P4HB—coronary artery disease	5.67e-06	9.09e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MTHFR—coronary artery disease	5.66e-06	9.08e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCA1—coronary artery disease	5.65e-06	9.06e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PSMA6—coronary artery disease	5.59e-06	8.97e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PSMB5—coronary artery disease	5.59e-06	8.97e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.58e-06	8.95e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	5.56e-06	8.92e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GGT1—coronary artery disease	5.51e-06	8.85e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GOT1—coronary artery disease	5.51e-06	8.85e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AGT—coronary artery disease	5.5e-06	8.82e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GOT1—coronary artery disease	5.47e-06	8.77e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GGT1—coronary artery disease	5.47e-06	8.77e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CTGF—coronary artery disease	5.46e-06	8.76e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMGCR—coronary artery disease	5.41e-06	8.68e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GOT2—coronary artery disease	5.41e-06	8.68e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOE—coronary artery disease	5.39e-06	8.64e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AGT—coronary artery disease	5.38e-06	8.62e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOA1—coronary artery disease	5.33e-06	8.54e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOE—coronary artery disease	5.27e-06	8.45e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—VCAN—coronary artery disease	5.24e-06	8.41e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALB—coronary artery disease	5.23e-06	8.39e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOA1—coronary artery disease	5.21e-06	8.35e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALDOA—coronary artery disease	5.2e-06	8.34e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—DCN—coronary artery disease	5.05e-06	8.1e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—NOS3—coronary artery disease	5e-06	8.03e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PLCB1—coronary artery disease	4.98e-06	7.98e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTP1—coronary artery disease	4.95e-06	7.95e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.91e-06	7.88e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTP1—coronary artery disease	4.91e-06	7.88e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	4.91e-06	7.87e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMOX1—coronary artery disease	4.89e-06	7.84e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.88e-06	7.83e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	4.87e-06	7.8e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMOX1—coronary artery disease	4.84e-06	7.77e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCA1—coronary artery disease	4.82e-06	7.74e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CAT—coronary artery disease	4.82e-06	7.73e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.79e-06	7.68e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HBA1—coronary artery disease	4.79e-06	7.68e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.79e-06	7.68e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LIPC—coronary artery disease	4.79e-06	7.68e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CAT—coronary artery disease	4.78e-06	7.67e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOC3—coronary artery disease	4.76e-06	7.63e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LDLR—coronary artery disease	4.73e-06	7.59e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARG—coronary artery disease	4.69e-06	7.53e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOB—coronary artery disease	4.68e-06	7.51e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.67e-06	7.5e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.67e-06	7.5e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GGT1—coronary artery disease	4.67e-06	7.49e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GOT1—coronary artery disease	4.67e-06	7.49e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOB—coronary artery disease	4.64e-06	7.44e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—POMC—coronary artery disease	4.63e-06	7.43e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GCLC—coronary artery disease	4.62e-06	7.41e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CETP—coronary artery disease	4.62e-06	7.41e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARG—coronary artery disease	4.59e-06	7.36e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—coronary artery disease	4.58e-06	7.34e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SDC1—coronary artery disease	4.57e-06	7.33e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTM1—coronary artery disease	4.55e-06	7.3e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—POMC—coronary artery disease	4.52e-06	7.26e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTM1—coronary artery disease	4.51e-06	7.24e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LPL—coronary artery disease	4.47e-06	7.17e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LPL—coronary artery disease	4.43e-06	7.11e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GPX1—coronary artery disease	4.36e-06	6.99e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GPX1—coronary artery disease	4.32e-06	6.93e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PSMA6—coronary artery disease	4.31e-06	6.92e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PSMB5—coronary artery disease	4.31e-06	6.92e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CD36—coronary artery disease	4.25e-06	6.81e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALB—coronary artery disease	4.22e-06	6.77e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CTGF—coronary artery disease	4.21e-06	6.76e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CD36—coronary artery disease	4.21e-06	6.75e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTP1—coronary artery disease	4.2e-06	6.73e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	4.19e-06	6.72e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMGCR—coronary artery disease	4.18e-06	6.7e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GOT2—coronary artery disease	4.18e-06	6.7e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	4.16e-06	6.67e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	4.16e-06	6.67e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMOX1—coronary artery disease	4.14e-06	6.64e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALB—coronary artery disease	4.13e-06	6.62e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CAT—coronary artery disease	4.08e-06	6.55e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NOS3—coronary artery disease	4.04e-06	6.48e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MTHFR—coronary artery disease	4.02e-06	6.45e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MTHFR—coronary artery disease	3.99e-06	6.4e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOB—coronary artery disease	3.96e-06	6.36e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NOS3—coronary artery disease	3.95e-06	6.33e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTM1—coronary artery disease	3.86e-06	6.19e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.84e-06	6.16e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AGT—coronary artery disease	3.82e-06	6.13e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AGT—coronary artery disease	3.79e-06	6.08e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LPL—coronary artery disease	3.79e-06	6.07e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOE—coronary artery disease	3.75e-06	6.01e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.72e-06	5.97e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOE—coronary artery disease	3.71e-06	5.96e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOA1—coronary artery disease	3.7e-06	5.94e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GPX1—coronary artery disease	3.69e-06	5.92e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—coronary artery disease	3.69e-06	5.92e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOA1—coronary artery disease	3.67e-06	5.89e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—coronary artery disease	3.61e-06	5.79e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GGT1—coronary artery disease	3.61e-06	5.78e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GOT1—coronary artery disease	3.61e-06	5.78e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CD36—coronary artery disease	3.6e-06	5.77e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	3.55e-06	5.7e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.51e-06	5.64e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTHFR—coronary artery disease	3.41e-06	5.47e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARG—coronary artery disease	3.26e-06	5.23e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.24e-06	5.2e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AGT—coronary artery disease	3.24e-06	5.19e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARG—coronary artery disease	3.23e-06	5.19e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—POMC—coronary artery disease	3.22e-06	5.16e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.21e-06	5.15e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.19e-06	5.12e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—POMC—coronary artery disease	3.19e-06	5.12e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOE—coronary artery disease	3.17e-06	5.09e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CAT—coronary artery disease	3.15e-06	5.06e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOA1—coronary artery disease	3.14e-06	5.03e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOB—coronary artery disease	3.06e-06	4.91e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3e-06	4.82e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.98e-06	4.77e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALB—coronary artery disease	2.93e-06	4.71e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LPL—coronary artery disease	2.92e-06	4.69e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALB—coronary artery disease	2.91e-06	4.66e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX1—coronary artery disease	2.85e-06	4.57e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CA—coronary artery disease	2.82e-06	4.52e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NOS3—coronary artery disease	2.81e-06	4.5e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NOS3—coronary artery disease	2.78e-06	4.46e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CD36—coronary artery disease	2.78e-06	4.45e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARG—coronary artery disease	2.76e-06	4.43e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.74e-06	4.4e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—POMC—coronary artery disease	2.73e-06	4.37e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.63e-06	4.22e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—coronary artery disease	2.57e-06	4.12e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.54e-06	4.08e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AGT—coronary artery disease	2.5e-06	4.01e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALB—coronary artery disease	2.49e-06	3.99e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOE—coronary artery disease	2.45e-06	3.93e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA1—coronary artery disease	2.42e-06	3.88e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NOS3—coronary artery disease	2.38e-06	3.81e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—coronary artery disease	2.3e-06	3.69e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CA—coronary artery disease	2.27e-06	3.64e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CA—coronary artery disease	2.22e-06	3.56e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—coronary artery disease	2.17e-06	3.49e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARG—coronary artery disease	2.13e-06	3.42e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—POMC—coronary artery disease	2.1e-06	3.37e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALB—coronary artery disease	1.92e-06	3.08e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—coronary artery disease	1.86e-06	2.98e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.83e-06	2.94e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—coronary artery disease	1.81e-06	2.91e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.68e-06	2.69e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.58e-06	2.53e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.57e-06	2.51e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.34e-06	2.15e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.29e-06	2.07e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—coronary artery disease	1.28e-06	2.05e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—coronary artery disease	1.09e-06	1.75e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.03e-06	1.66e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—coronary artery disease	8.43e-07	1.35e-05	CbGpPWpGaD
